enGene Therapeutics Inc. Convertible Debt
Discontinued › Balance Sheet › Liabilities
us-gaap:ConvertibleDebt · last filed 2024-01-29
- 2023-10-31: Convertible Debt $0.00.
- 2022-10-31: Convertible Debt $17.41M.
| Period end | Convertible Debt |
|---|---|
| 2023-10-31 | $0.00 10-K · filed 2024-01-29 |
| 2022-10-31 | $17.41M 10-K · filed 2024-01-29 |